Rubric Capital Management LP
13F Reported Value
ⓘ$10.9B
Holdings
87
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
Rubric Capital Management LP disclosed 87 positions worth $10.9B in its Form 13F-HR for Q2 2026, led by $TLN (Talen Energy Corp) at 12.7% of the equity portfolio, followed by $FTAI and $VTRS. During the quarter the fund opened 18 new positions and exited 14 — including a new stake in $FLR. The portfolio is most concentrated in Healthcare (33.6% of disclosed assets). All figures are sourced directly from Rubric Capital Management LP’s Form 13F-HR filing with the SEC under CIK 1687509.
AI Fund Analysis
DiversifyingSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- 57.2#1,112
Quality
$1.4B3,602,171 sh - —
Quality
$811.6M3,000,000 sh - 45.4#1,869
Quality
$542.6M34,168,743 sh - $527.7M15,575,000 sh
- —
Quality
$457.5M9,178,978 sh - 71.9
Quality
$284.7M1,794,953 sh - —
Quality
$279.8M20,232,011 sh - 47.6
Quality
$262.9M5,017,248 sh - $255.8M3,999,800 sh
- 71.9
Quality
$254.4M23,800,000 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 Talen Energy Corp$TLN | 57.2#1,112 | $1.4B | 3,602,171 |
 FTAI Aviation Ltd.$FTAI | — | $811.6M | 3,000,000 |
 Viatris Inc$VTRS | 45.4#1,869 | $542.6M | 34,168,743 |
 TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA | — | $527.7M | 15,575,000 |
 GOLAR LNG LTD$GLNG | — | $457.5M | 9,178,978 |
 Vistra Corp.$VST | 71.9 | $284.7M | 1,794,953 |
 TRANSALTA CORP$TAC | — | $279.8M | 20,232,011 |
 FLUOR CORP$FLR | 47.6 | $262.9M | 5,017,248 |
 Kiniksa Pharmaceuticals International, plc$KNSA | — | $255.8M | 3,999,800 |
 BGC Group, Inc.$BGC | 71.9 | $254.4M | 23,800,000 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Rubric Capital Management LP's 87 positions.
Showing top 10 of 87 holdings.
Sector Allocation
Healthcare
$3.7B
Utilities
$2.0B
Industrials
$1.7B
Consumer Discretionary
$757.3M
Communication Services
$714.5M
Financials
$630.9M
Technology
$414.9M
Consumer Staples
$299.4M
Full Holdings — Rubric Capital Management LP (Q2 2026)
All 87 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $TLN | Talen Energy Corp | $1.4B | 12.7% | +0% | 57.2 |
| 2 | $FTAI | FTAI Aviation Ltd. | $811.6M | 7.5% | +16% | — |
| 3 | $VTRS | Viatris Inc | $542.6M | 5.0% | +2% | 45.4 |
| 4 | $TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | $527.7M | 4.8% | +2% | — |
| 5 | $GLNG | GOLAR LNG LTD | $457.5M | 4.2% | +0% | — |
| 6 | $VST | Vistra Corp. | $284.7M | 2.6% | +20% | 71.9 |
| 7 | $TAC | TRANSALTA CORP | $279.8M | 2.6% | +14% | — |
| 8 | $FLR | FLUOR CORP | $262.9M | 2.4% | NEW | 47.6 |
| 9 | $KNSA | Kiniksa Pharmaceuticals International, plc | $255.8M | 2.4% | +7% | — |
| 10 | $BGC | BGC Group, Inc. | $254.4M | 2.3% | +2% | 71.9 |
| 11 |  $ZM | Zoom Communications, Inc. | $238.7M | 2.2% | +176% | 70.5 |
| 12 |  $GIL | Gildan Activewear Inc. | $232.2M | 2.1% | +222% | — |
| 13 |  $ARQT | Arcutis Biotherapeutics, Inc. | $216.9M | 2.0% | +0% | 62.9 |
| 14 |  $AMZN | AMAZON COM INC | $214.5M | 2.0% | NEW | 68.7 |
| 15 |  $ROIV | Roivant Sciences Ltd. | $212.3M | 1.9% | +20% | — |
| 16 |  $ZYME | Zymeworks Inc. | $183.0M | 1.7% | +0% | 8.7 |
| 17 |  $AMCR | Amcor plc | $180.4M | 1.7% | +228% | — |
| 18 |  $CMPR | CIMPRESS plc | $178.0M | 1.6% | +7% | — |
| 19 |  $AMRX | Amneal Pharmaceuticals, Inc. | $176.0M | 1.6% | -8% | 58.5 |
| 20 |  $NRIX | Nurix Therapeutics, Inc. | $175.3M | 1.6% | +192% | 6.4 |
| 21 |  $MCY | MERCURY GENERAL CORP | $164.3M | 1.5% | -28% | 76.6 |
| 22 |  $PFSI | PennyMac Financial Services, Inc. | $148.1M | 1.4% | +3006% | 62.8 |
| 23 |  $IART | INTEGRA LIFESCIENCES HOLDINGS CORP | $139.3M | 1.3% | +0% | 48.2 |
| 24 |  $DK | Delek US Holdings, Inc. | $136.5M | 1.3% | +0% | 50.8 |
| 25 |  $LBTYA | Liberty Global Ltd. | $133.6M | 1.2% | +0% | — |
| 26 |  $MGTX | MeiraGTx Holdings plc | $122.9M | 1.1% | +30% | — |
| 27 |  $GEO | GEO GROUP INC | $122.1M | 1.1% | +10% | 54.5 |
| 28 |  $LILA | Liberty Latin America Ltd. | $121.9M | 1.1% | +2% | — |
| 29 |  $SDGR | Schrodinger, Inc. | $104.0M | 0.9% | +7% | 33 |
| 30 |  $ECVT | Ecovyst Inc. | $102.2M | 0.9% | -10% | 48.7 |
| 31 | $LBTYA | Liberty Global Ltd. | $101.9M | 0.9% | +0% | — |
| 32 |  $COMP | Compass, Inc. | $101.3M | 0.9% | +119% | 61.2 |
| 33 |  $NWL | NEWELL BRANDS INC. | $98.2M | 0.9% | +5% | 42.4 |
| 34 |  $EPC | EDGEWELL PERSONAL CARE Co | $95.2M | 0.9% | -11% | 35.1 |
| 35 |  $CXW | CoreCivic, Inc. | $86.5M | 0.8% | +38% | 57.1 |
| 36 |  $ARDX | ARDELYX, INC. | $82.6M | 0.8% | +771% | 41.9 |
| 37 |  $ENOV | Enovis CORP | $80.7M | 0.7% | +59% | 39.5 |
| 38 |  $ADMA | ADMA BIOLOGICS, INC. | $78.2M | 0.7% | +416% | 69.7 |
| 39 |  $MNKD | MANNKIND CORP | $76.7M | 0.7% | +397% | 37.2 |
| 40 |  $DRVN | Driven Brands Holdings Inc. | $73.9M | 0.7% | +77% | 54.9 |
| 41 |  $OPK | OPKO HEALTH, INC. | $71.7M | 0.7% | +0% | 23.3 |
| 42 |  $AVO | Mission Produce, Inc. | $70.5M | 0.7% | +246% | 49.6 |
| 43 |  $ADEA | Adeia Inc. | $70.0M | 0.6% | -50% | 70.2 |
| 44 |  $RNW | ReNew Energy Global plc | $68.8M | 0.6% | +0% | — |
| 45 |  $SSYS | STRATASYS LTD. | $68.5M | 0.6% | +0% | — |
| 46 |  $SPRY | ARS Pharmaceuticals, Inc. | $68.4M | 0.6% | +7% | 20.3 |
| 47 |  $ANDE | Andersons, Inc. | $68.4M | 0.6% | +17% | 48.7 |
| 48 |  $PRMB | Primo Brands Corp | $65.3M | 0.6% | -4% | 60 |
| 49 |  $SON | SONOCO PRODUCTS CO | $64.4M | 0.6% | NEW | 69 |
| 50 |  $STUB | StubHub Holdings, Inc. | $64.3M | 0.6% | NEW | 49.3 |
| 51 |  $GLXY | Galaxy Digital Inc. | $64.1M | 0.6% | NEW | 62.7 |
| 52 |  $VG | Venture Global, Inc. | $60.2M | 0.6% | +261% | 69.5 |
| 53 |  $ESTA | ESTABLISHMENT LABS HOLDINGS INC. | $59.1M | 0.5% | NEW | 33.9 |
| 54 |  $QDEL | QuidelOrtho Corp | $57.9M | 0.5% | +0% | 28.2 |
| 55 |  $ALVO | Alvotech | $57.8M | 0.5% | NEW | — |
| 56 |  $TH | Target Hospitality Corp. | $52.7M | 0.5% | +18% | 40.4 |
| 57 |  $DNOW | DNOW Inc. | $50.6M | 0.5% | +208% | 48.8 |
| 58 | — | PROTHENA CORP PLC - SHS | $49.0M | 0.5% | +0% | — |
| 59 |  $TRVI | Trevi Therapeutics, Inc. | $46.7M | 0.4% | -33% | — |
| 60 |  $COLL | COLLEGIUM PHARMACEUTICAL, INC | $46.3M | 0.4% | +0% | 62.7 |
| 61 |  $ABUS | Arbutus Biopharma Corp | $36.2M | 0.3% | +14% | 7.3 |
| 62 | — | VERSIGENT PLC - ORDINARY SHARES | $35.9M | 0.3% | NEW | — |
| 63 |  $XPER | Xperi Inc. | $34.1M | 0.3% | +0% | 26.4 |
| 64 |  $OFIX | Orthofix Medical Inc. | $34.0M | 0.3% | +0% | 38.2 |
| 65 |  $TRIP | TripAdvisor, Inc. | $33.4M | 0.3% | NEW | 40.8 |
| 66 |  $MATV | Mativ Holdings, Inc. | $30.1M | 0.3% | +0% | 52.8 |
| 67 | $LILA | Liberty Latin America Ltd. | $29.6M | 0.3% | +1% | — |
| 68 |  $BHVN | Biohaven Ltd. | $25.6M | 0.2% | NEW | — |
| 69 |  $VISN | Vistance Networks, Inc. | $25.6M | 0.2% | +0% | 33.8 |
| 70 |  $ANIP | ANI PHARMACEUTICALS INC | $21.4M | 0.2% | NEW | 72.5 |
| 71 |  $QURE | uniQure N.V. | $18.8M | 0.2% | NEW | — |
| 72 |  $HPP | Hudson Pacific Properties, Inc. | $15.5M | 0.1% | NEW | 28.2 |
| 73 |  $SEG | Seaport Entertainment Group Inc. | $15.1M | 0.1% | +0% | 16.2 |
| 74 |  $GDS | GDS Holdings Ltd | $14.6M | 0.1% | NEW | — |
| 75 |  $HRTX | HERON THERAPEUTICS, INC. /DE/ | $12.8M | 0.1% | +0% | 24.7 |
| 76 |  $PRLB | Proto Labs Inc | $8.9M | 0.1% | -78% | 53.5 |
| 77 |  $AERO | Grupo Aeromexico, S.A.B. de C.V. | $8.4M | 0.1% | +0% | — |
| 78 |  $OMER | OMEROS CORP | $6.2M | 0.1% | NEW | — |
| 79 |  $EPRX | EUPRAXIA PHARMACEUTICALS INC. | $5.7M | 0.1% | +26% | — |
| 80 |  $EDSA | Edesa Biotech, Inc. | $5.4M | 0.1% | -3% | — |
| 81 |  $MREO | Mereo BioPharma Group plc | $4.9M | 0.0% | +0% | — |
| 82 |  $ABEO | ABEONA THERAPEUTICS INC. | $3.8M | 0.0% | NEW | 23.7 |
| 83 |  $CRI | CARTERS INC | $3.6M | 0.0% | -91% | 58.1 |
| 84 |  $TXMD | TherapeuticsMD, Inc. | $2.6M | 0.0% | +0% | — |
| 85 | $OPK | OPKO HEALTH, INC. | $1.9M | 0.0% | +0% | 23.3 |
| 86 |  $TTI | TETRA TECHNOLOGIES INC | $1.7M | 0.0% | NEW | 38.3 |
| 87 |  $SVC | Service Properties Trust | $1.5M | 0.0% | NEW | 35.7 |
New Positions (18)
$FLR FLUOR CORP$262.9M$AMZN AMAZON COM INC$214.5M$SON SONOCO PRODUCTS CO$64.4M$STUB StubHub Holdings, Inc.$64.3M$GLXY Galaxy Digital Inc.$64.1M$ESTA ESTABLISHMENT LABS HOLDINGS INC.$59.1M$ALVO Alvotech$57.8M$TRIP TripAdvisor, Inc.$33.4M$BHVN Biohaven Ltd.$25.6M$ANIP ANI PHARMACEUTICALS INC$21.4M$QURE uniQure N.V.$18.8M$HPP Hudson Pacific Properties, Inc.$15.5M$GDS GDS Holdings Ltd$14.6M$OMER OMEROS CORP$6.2MExited Positions (14)
$CEG Constellation Energy Corp
$AKAM AKAMAI TECHNOLOGIES INC
$TDS TELEPHONE & DATA SYSTEMS INC /DE/
$PTGX Protagonist Therapeutics, Inc
$CVGW CALAVO GROWERS INC
$TSAT Telesat Corp
$BMRN BIOMARIN PHARMACEUTICAL INC
$INDV Indivior Pharmaceuticals, Inc.
$ACHC Acadia Healthcare Company, Inc.
$CPRI Capri Holdings Ltd
$EMBC Embecta Corp.
$HELE HELEN OF TROY LTD
$MYPS PLAYSTUDIOS, Inc.Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Rubric Capital Management LP including:
Track Rubric Capital Management LP's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Rubric Capital Management LP and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Rubric Capital Management LP
13F Pro is an AI hedge fund tracker and stock research platform. For Rubric Capital Management LP (SEC CIK: 1687509), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Rubric Capital Management LP's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.